Latest Content

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

March 6th 2025, 2:01pm

By Ryan Scott

Article

Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.

Thermal Ablation Noninferior to Surgery in Small-Size Colorectal Liver Metastases

March 5th 2025, 10:00pm

By Ryan Scott

Article

Treatment with thermal ablation was noninferior to surgical resection in small-size colorectal liver metastases, according to the COLLISION trial.

Organ-Sparing Treatments Bring New Life After Cancer

March 5th 2025, 8:00pm

By Sonya Collins

Article

Avoiding surgery for rectal cancer, Sarah Rack of Memphis traveled to Houston for treatment every three weeks for 18 months.

Becoming a Better Version of Me After Breast Cancer

March 5th 2025, 6:00pm

By Bonnie Annis

Article

A revelation has given me perspective for the New Year, inspiring me to embrace change, set new goals and upgrade myself to a better version in 2025.

Colostomies and Colon Cancer, a Lifesaving Choice, Not a Last Resort

March 5th 2025, 5:00pm

By Dr. Andreas M. Kaiser

Video

Dr. Andreas M. Kaiser explains how a colostomy may preserve a patient’s health and help to avoid colorectal cancer complications.

Brukinsa Combo Shows Efficacy and Safety For Double-Expressor Lymphoma

March 5th 2025, 4:09pm

By Spencer Feldman

Article

Brukinsa plus R-CHOP demonstrated high efficacy and durable responses in double-expressor lymphoma, with manageable safety, supporting further phase 3 trials.

Biomarkers, Genetic Testing and More Make Way in GU Cancers

March 5th 2025, 2:00pm

By Ryan Scott

Article

Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies across kidney, bladder and prostate cancers.

Verzenio Combo May Improve Survival in HR+/HER2– Advanced Breast Cancer

March 4th 2025, 10:00pm

By Spencer Feldman

Article

Verzenio plus Faslodex improved progression-free survival in HR+/HER2– advanced breast cancer after CDK/6i failure, with a manageable safety profile.

Better Understanding Genetic Mutations Influence in Cancer Care

March 4th 2025, 8:02pm

By Dr. Guru Sonpavde

Video

Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.

Breast Cancer And Depending On The Kindness Of Strangers

March 4th 2025, 6:00pm

By Laura Yeager

Article

I reflect on my unexpected bond with a neighbor during my breast cancer treatment, finding comfort in his company when I needed someone to talk to.

Enhertu Associated With Survival Increase in HER2+ Metastatic Gastric Cancer

March 4th 2025, 5:00pm

By Spencer Feldman

Article

Enhertu improved overall survival versus chemotherapy in HER2-positive metastatic gastric cancer, prompting an interim analysis and potential regulatory approvals.

Checkpoint Inhibitor Therapy and ISRT Maintains Outcomes in Younger Patients With cHL

March 4th 2025, 4:00pm

By Ryan Scott

Article

Replacing transplant and chemo with CI-based therapy and ISRT maintains survival, reduces side effects in younger patients with classic Hodgkin lymphoma.

FDA Approves Tevimbra Plus Chemotherapy For Some With Esophageal Cancer

March 4th 2025, 1:39pm

By Alex Biese

Article

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1.

Expert Explains Safety of Krazati Regimen For Treating Colorectal Cancer

March 3rd 2025, 10:00pm

By Dr. Nataliya Uboha

Video

Krazati plus Erbitux is well tolerated in KRAS G12C-mutant metastatic colorectal cancer, with manageable side effects and less immune suppression.

Immune Checkpoint Inhibitors For Cancer Associated With Psoriasis Risk

March 3rd 2025, 8:00pm

By Alex Biese

Article

Researchers have discovered a strong association between the use of immune checkpoint inhibitors for cancer treatment and a risk of new onset psoriasis.